ARTICLE

FindCenter AddIcon

Psychedelic Therapy and Racial Trauma: Offering Clients a Deeper Experience of Healing

By Chris Lyford — 2021

Like most people of color in the United States, psychotherapist and researcher Monnica Williams has experienced myriad forms of racism. Early in her career, understanding its effects on her mind and body motivated her to help clients address their own racial trauma in therapy.

Read on www.psychotherapynetworker.org

FindCenter Post-Image

Race and Healing: Expanding the Conversation

Now, more than ever, people want to engage in meaningful dialogue about race and racism. It’s a vital goal, but how do we translate intention into practice? In the therapy world, what are clinicians of color telling their white colleagues?

Article
Gail Parker, S. Kent Butler, Amber Flynn, Deran Young, Lambers Fisher, Monnica Williams, Zachary Taylor
2020
FindCenter AddIcon
FindCenter Post-Image

Psychedelic Drugs Can Help Treat PTSD Caused by Racism, Discrimination: Researchers

Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.

Article
Avis Favaro, Elizabeth St. Philip, Solarina Ho
2021
FindCenter AddIcon
FindCenter Post-Image

Meet the Psychologist Using Psychedelics to Treat Racial Trauma

People of color are dealing with racism all the time, in large and small ways, and even dealing with racism in healthcare, even dealing with racism in therapy.

Article
Robin Donovan
2021
FindCenter AddIcon
FindCenter Post-Image

Psychedelic Psychotherapy Is Coming: Who Will Be Included?

A new study finds widespread exclusion of minorities in psychedelic research.

Article
Monnica T. Williams
2018
FindCenter AddIcon
FindCenter Post-Image

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

Article
Steph Yin
2020
FindCenter AddIcon
FindCenter Post-Image

Who Will Benefit From Psychedelic Medicine?

These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.

Article
Whitney Joiner
2020
FindCenter AddIcon
FindCenter Post-Image

Psychedelics Shown to Ease the Effects of Racial Trauma

A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).

Article
Kristi Pahr
2021
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Therapy May Work as Well as Common Antidepressant

The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.

Article
Zoe Cormier
2021
FindCenter AddIcon
FindCenter Post-Image

21-Day Racial Equity Indigenous Challenge – Fighting White Supremacy Since 1492

“Just a reminder: the system in what is currently known as the US isn’t ‘broken.’ It was designed by male white supremacist slaveowners on stolen Indigenous land to protect their interests. It’s working as it was designed.” ~Dr. Adrienne Keene (Cherokee)

Article
Dr. Eddie Moore
FindCenter AddIcon
FindCenter Post-Image

The Intersectionality Wars

When Kimberlé Crenshaw coined the term 30 years ago, it was a relatively obscure legal concept. Then it went viral.

Article
Jane Coaston
2019
FindCenter AddIcon

EXPLORE TOPIC

MDMA